FBT
AZN icon

First Bankers Trust’s AstraZeneca AZN Stock Holding History

First Bankers Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
6,717
-134
-2% -$25.2K 0.4% 76
2026
Q1 		$1.35M Sell
6,851
-1
-0% -$193 0.46% 69
2025
Q4 		$1.26M Sell
6,852
-30
-0.4% -$5.26K 0.42% 71
2025
Q3 		$1.06M Sell
6,882
-833
-11% -$126K 0.37% 79
2025
Q2 		$1.08M Buy
7,715
+20
+0.3% +$2.8K 0.4% 75
2025
Q1 		$1.13M Sell
7,695
-247
-3% -$35.7K 0.45% 70
2024
Q4 		$1.04M Sell
7,942
-20
-0.3% -$2.8K 0.41% 65
2024
Q3 		$1.24M Sell
7,962
-265
-3% -$42.8K 0.48% 64
2024
Q2 		$1.28M Sell
8,227
-875
-10% -$132K 0.53% 57
2024
Q1 		$1.23M Hold
9,102
– – 0.53% 61
2023
Q4 		$1.23M Hold
9,102
– – 0.57% 56
2023
Q3 		$1.23M Hold
9,102
– – 0.62% 53
2023
Q2 		$1.3M Sell
9,102
-40
-0.4% -$5.88K 0.64% 54
2023
Q1 		$1.27M Sell
9,142
-92
-1% -$12.4K 0.64% 56
2022
Q4 		$1.25M Hold
9,234
– – 0.64% 54
2022
Q3 		$1.01M Hold
9,234
– – 0.58% 57
2022
Q2 		$1.22M Sell
9,234
-300
-3% -$39.4K 0.64% 50
2022
Q1 		$1.26M Sell
9,534
-551
-5% -$66.1K 0.59% 54
2021
Q4 		$1.18M Sell
10,085
-300
-3% -$35.3K 0.52% 66
2021
Q3 		$1.25M Sell
10,385
-671
-6% -$78.1K 0.63% 55
2021
Q2 		$1.32M Sell
11,056
-1,200
-10% -$132K 0.65% 52
2021
Q1 		$1.22M Sell
12,256
-1,400
-10% -$141K 0.51% 63
2020
Q4 		$1.36M Sell
13,656
-185
-1% -$19.6K 0.53% 58
2020
Q3 		$1.52M Sell
13,841
-160
-1% -$17.8K 0.64% 59
2020
Q2 		$1.48M Sell
14,001
-138
-1% -$14.3K 0.66% 57
2020
Q1 		$1.26M Sell
14,139
-50
-0.4% -$4.71K 0.65% 57
2019
Q4 		$1.42M Sell
14,189
-129
-0.9% -$12.1K 0.6% 58
2019
Q3 		$1.28M Sell
14,318
-1,787
-11% -$155K 0.58% 61
2019
Q2 		$1.33M Sell
16,105
-1,859
-10% -$146K 0.61% 54
2019
Q1 		$1.45M Sell
17,964
-20,013
-53% -$1.58M 0.69% 47
2018
Q4 		$2.88M Buy
37,977
+16,938
+81% +$1.32M 0.75% 43
2018
Q3 		$1.67M Sell
21,039
-1,750
-8% -$132K 0.79% 40
2018
Q2 		$1.6M Sell
22,789
-1,575
-6% -$113K 0.83% 40
2018
Q1 		$1.7M Sell
24,364
-933
-4% -$64.6K 0.9% 40
2017
Q4 		$1.76M Buy
25,297
+470
+2% +$31.7K 0.87% 40
2017
Q3 		$1.68M Sell
24,827
-275
-1% -$17.4K 0.87% 40
2017
Q2 		$1.71M Sell
25,102
-175
-0.7% -$11.4K 0.92% 40
2017
Q1 		$1.57M Sell
25,277
-575
-2% -$33.5K 0.86% 41
2016
Q4 		$1.41M Sell
25,852
-1,050
-4% -$59.6K 0.78% 42
2016
Q3 		$1.77M Buy
26,902
+575
+2% +$37.6K 0.99% 35
2016
Q2 		$1.59M Sell
26,327
-9,996
-28% -$581K 0.88% 44
2016
Q1 		$2.05M Sell
36,323
-420
-1% -$25.2K 0.86% 42
2015
Q4 		$2.5M Buy
36,743
+615
+2% +$40.3K 1.09% 34
2015
Q3 		$2.3M Sell
36,128
-87
-0.2% -$5.72K 1.06% 36
2015
Q2 		$2.31M Buy
36,215
+600
+2% +$41.1K 0.98% 36
2015
Q1 		$2.44M Buy
35,615
+425
+1% +$29.5K 1.05% 36
2014
Q4 		$2.48M Buy
35,190
+210
+0.6% +$15K 1.08% 31
2014
Q3 		$2.5M Buy
34,980
+100
+0.3% +$7.32K 1.1% 31
2014
Q2 		$2.59M Buy
34,880
+264
+0.8% +$19.1K 1.14% 30
2014
Q1 		$2.25M Sell
34,616
-100
-0.3% -$6.46K 1.05% 33
2013
Q4 		$2.06M Buy
34,716
+900
+3% +$48.9K 0.98% 33
2013
Q3 		$1.76M Buy
33,816
+1,860
+6% +$93.4K 0.93% 36
2013
Q2 		$1.51M Buy
+31,956
New +$1.63M 0.82% 43

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

First Bankers Trust's AZN Position: Q2 2026 in Review

First Bankers Trust reduced its AstraZeneca (AZN) stake by 2% in Q2 2026, selling an estimated $25.2K and leaving 6,717 shares worth $1.27M. The position accounts for 0.4% of the portfolio, ranked #76.

First Bankers Trust first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.88M in Q4 2018. 454 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • First Bankers Trust held 6,717 shares of AstraZeneca worth $1.27M as of Q2 2026.
  • First Bankers Trust sold 134 AstraZeneca shares in Q2 2026, an estimated $25.2K.
  • AstraZeneca made up 0.4% of First Bankers Trust's portfolio in Q2 2026, its #76 holding.
  • First Bankers Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
  • First Bankers Trust's AstraZeneca position peaked at $2.88M in Q4 2018.
  • 454 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First Bankers Trust's 13F filing for Q2 2026, filed 9 Jul 2026.